1032
PROTEOMIC BIOMARKER PROFILING OF AMPULLARY ADENOCARCINOMA (AMPAC) WITHIN THE LANDSCAPE OF PERIAMPULLARY CARCINOMAS TO GUIDE CLINICAL DECISION-MAKING
Date
May 21, 2024
Tracks
Related Products
IMPACT OF LIVER CIRRHOSIS ON SURGICAL COMPLICATIONS, TIME TO RECURRENCE, AND OVERALL SURVIVAL FOLLOWING RESECTION OF PANCREATIC DUCTAL ADENOCARCINOMA: A PROPENSITY-MATCHED STUDY
Management of patients with margin negative, T1-T3, N0 (stage IB–IIIA), resected gallbladder cancer (GBC) remains poorly defined. Current guidelines consider observation, chemotherapy (CT), and chemoradiation (CRT) as options…
AGGRESSIVE MANAGEMENT OF ELDERLY PATIENTS WITH NON-METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
METABOLOMIC CHARACTERIZATION OF PANCREATIC JUICE IN PANCREATIC CANCER: A NOVEL PROGNOSTIC TOOL?
INTRODUCTION: Analysis of metabolites in body fluids through mass spectrometry-based metabolomics is one of the key technologies to identify disease-specific profiles in different malignancies…
Hepatobiliary and Pancreatic Diseases
SOCIETY: SSAT